Regenerative Medical Technology Group Inc. (RMTG) › Cash & EquivalentsRegenerative Medical Technology Group Inc. (RMTG) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2016: $6.6K2017: $7.8K2018: $30.8K2019: $23.4K2020: $42.5K2021: $2.98M2022: $1.65M2023: $530.5K2024: $1.17M2025: $956.7K$956.7K2016Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$956.7K-17.9%2024$1.17M+119.7%2023$530.5K-67.8%2022$1.65M-44.8%2021$2.98M+6902.7%2020$42.5K+81.9%2019$23.4K-24.2%2018$30.8K+297.9%2017$7.8K+16.6%2016$6.6K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share